» Articles » PMID: 33520359

Detection of Carcinoma in Serous Effusions: a Review

Overview
Journal Am J Cancer Res
Specialty Oncology
Date 2021 Feb 1
PMID 33520359
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A malignant serous effusion is one of the most common complications of advanced tumors, indicating a poor prognosis and having a profound impact on diagnosis, treatment, and prognosis. It is of great significance to identify benign and malignant effusions quickly and accurately. Both cellular and non-cellular components in the effusion can be employed for detection, diagnostic methods are necessary to obtain a definite diagnosis and more relevant information such as tumor classification. In this review, we focus on the comparison of several widespread cytological preparation methods, enrichment technology of exfoliated cells, and present tests for serous effusions, mainly including routine and special stains, immunocytochemistry, electron microscopy, enzyme-linked immunosorbent assay, flow cytometry, and molecular analysis.

Citing Articles

Plasmacytic Pleural Effusion as a Major Presentation of Angioimmunoblastic T-Cell Lymphoma: A Case Report.

Li B, Nong L, Zhang J, Wang W, Wang Q, Zhang Y Curr Oncol. 2022; 29(10):7637-7644.

PMID: 36290880 PMC: 9600574. DOI: 10.3390/curroncol29100603.


Diagnostic Value of Claudin-4 and EZH2 Immunohistochemistry in Effusion Cytology.

Elhosainy A, Hafez M, Yassin E, Adam M, Elnaggar M, Aboulhagag N Asian Pac J Cancer Prev. 2022; 23(8):2779-2785.

PMID: 36037134 PMC: 9741875. DOI: 10.31557/APJCP.2022.23.8.2779.


Initial panel of immunocytochemical markers for identification of primary carcinoma site for effusions and peritoneal washings from women.

Takano G, Amorim R, Ferreira V, Vianna L, Castro T, Carneiro M Int J Clin Exp Pathol. 2022; 15(4):191-200.

PMID: 35535203 PMC: 9077109.


Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysis.

Xue J, Liu H, Meng G, Ding Z, Yan L, Yao S Cancer Immunol Immunother. 2021; 71(7):1633-1644.

PMID: 34750662 PMC: 10992106. DOI: 10.1007/s00262-021-03103-2.

References
1.
Salyer W, Eggleston J, Erozan Y . Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura. Chest. 1975; 67(5):536-9. DOI: 10.1378/chest.67.5.536. View

2.
Corcoran J, Psallidas I, Wrightson J, Hallifax R, Rahman N . Pleural procedural complications: prevention and management. J Thorac Dis. 2015; 7(6):1058-67. PMC: 4466427. DOI: 10.3978/j.issn.2072-1439.2015.04.42. View

3.
Krishan A, Ganjei-Azar P, Hamelik R, Sharma D, Reis I, Nadji M . Flow immunocytochemistry of marker expression in cells from body cavity fluids. Cytometry A. 2009; 77(2):132-43. DOI: 10.1002/cyto.a.20824. View

4.
Engels M, Michael C, Dobra K, Hjerpe A, Fassina A, Firat P . Management of cytological material, pre-analytical procedures and bio-banking in effusion cytopathology. Cytopathology. 2018; 30(1):31-38. DOI: 10.1111/cyt.12654. View

5.
Matreja S, Malukani K, Nandedkar S, Varma A, Saxena A, Ajmera A . Comparison of efficacy of cell block versus conventional smear study in exudative fluids. Niger Postgrad Med J. 2018; 24(4):245-249. DOI: 10.4103/npmj.npmj_150_17. View